Redox-activatable and acid-enhanced nanotheranostics for second near-infrared photoacoustic tomography and combined photothermal tumor therapy
Tumor phototheranostics in the second near-infrared window (NIR-II, 1000-1700 nm) holds great promise due to high spatiotemporal precision, enhanced penetration depth, and therapeutic efficacy. However, current "always-on" NIR-II phototheranostic agents remain restricted by the inherent no...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/146533 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-146533 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-1465332021-02-25T02:52:23Z Redox-activatable and acid-enhanced nanotheranostics for second near-infrared photoacoustic tomography and combined photothermal tumor therapy Wang, Zhimin Zhen, Xu Upputuri, Paul Kumar Jiang, Yuyan Lau, Junwei Pramanik, Manojit Pu, Kanyi Xing, Bengang School of Chemical and Biomedical Engineering Engineering::Bioengineering Tumor Microenvironment Activatable Nanotheranostics Tumor phototheranostics in the second near-infrared window (NIR-II, 1000-1700 nm) holds great promise due to high spatiotemporal precision, enhanced penetration depth, and therapeutic efficacy. However, current "always-on" NIR-II phototheranostic agents remain restricted by the inherent nonspecificity from the pseudosignal readout and undesirable treatment-related side effects. To address these challenges, herein we explore an activatable and biocompatible nanotheranostics that generates diagnostic and therapeutic effects only after specific activation and enhancement by tumor microenvironmental redox and acid while keeping silent at normal tissues. Such an intelligent "turn-on" chromogenic nanotheranostics allows in vivo nearly zero-background photoacoustic tomography (PAT) and combined effective photothermal tumor therapy (PTT) both in the NIR-II range with minimal adverse effects. In light of the high sensitivity, superior penetration depth, and biocompatibility, this stimuli-activatable NIR-II photo-nanotheranostics provides broad prospects for the investigation and intervention of deep-tissue redox and acid-associated physiological and pathological events. 2021-02-25T02:52:23Z 2021-02-25T02:52:23Z 2019 Journal Article Wang, Z., Zhen, X., Upputuri, P. K., Jiang, Y., Lau, J., Pramanik, M., ... Xing, B. (2019). Redox-activatable and acid-enhanced nanotheranostics for second near-infrared photoacoustic tomography and combined photothermal tumor therapy. ACS Nano, 13(5), 5816-5825. doi:10.1021/acsnano.9b01411 1936-086X 0000-0002-8064-6009 0000-0002-8391-1234 https://hdl.handle.net/10356/146533 10.1021/acsnano.9b01411 31034202 2-s2.0-85065776756 5 13 5816 5825 en ACS Nano |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
Engineering::Bioengineering Tumor Microenvironment Activatable Nanotheranostics |
spellingShingle |
Engineering::Bioengineering Tumor Microenvironment Activatable Nanotheranostics Wang, Zhimin Zhen, Xu Upputuri, Paul Kumar Jiang, Yuyan Lau, Junwei Pramanik, Manojit Pu, Kanyi Xing, Bengang Redox-activatable and acid-enhanced nanotheranostics for second near-infrared photoacoustic tomography and combined photothermal tumor therapy |
description |
Tumor phototheranostics in the second near-infrared window (NIR-II, 1000-1700 nm) holds great promise due to high spatiotemporal precision, enhanced penetration depth, and therapeutic efficacy. However, current "always-on" NIR-II phototheranostic agents remain restricted by the inherent nonspecificity from the pseudosignal readout and undesirable treatment-related side effects. To address these challenges, herein we explore an activatable and biocompatible nanotheranostics that generates diagnostic and therapeutic effects only after specific activation and enhancement by tumor microenvironmental redox and acid while keeping silent at normal tissues. Such an intelligent "turn-on" chromogenic nanotheranostics allows in vivo nearly zero-background photoacoustic tomography (PAT) and combined effective photothermal tumor therapy (PTT) both in the NIR-II range with minimal adverse effects. In light of the high sensitivity, superior penetration depth, and biocompatibility, this stimuli-activatable NIR-II photo-nanotheranostics provides broad prospects for the investigation and intervention of deep-tissue redox and acid-associated physiological and pathological events. |
author2 |
School of Chemical and Biomedical Engineering |
author_facet |
School of Chemical and Biomedical Engineering Wang, Zhimin Zhen, Xu Upputuri, Paul Kumar Jiang, Yuyan Lau, Junwei Pramanik, Manojit Pu, Kanyi Xing, Bengang |
format |
Article |
author |
Wang, Zhimin Zhen, Xu Upputuri, Paul Kumar Jiang, Yuyan Lau, Junwei Pramanik, Manojit Pu, Kanyi Xing, Bengang |
author_sort |
Wang, Zhimin |
title |
Redox-activatable and acid-enhanced nanotheranostics for second near-infrared photoacoustic tomography and combined photothermal tumor therapy |
title_short |
Redox-activatable and acid-enhanced nanotheranostics for second near-infrared photoacoustic tomography and combined photothermal tumor therapy |
title_full |
Redox-activatable and acid-enhanced nanotheranostics for second near-infrared photoacoustic tomography and combined photothermal tumor therapy |
title_fullStr |
Redox-activatable and acid-enhanced nanotheranostics for second near-infrared photoacoustic tomography and combined photothermal tumor therapy |
title_full_unstemmed |
Redox-activatable and acid-enhanced nanotheranostics for second near-infrared photoacoustic tomography and combined photothermal tumor therapy |
title_sort |
redox-activatable and acid-enhanced nanotheranostics for second near-infrared photoacoustic tomography and combined photothermal tumor therapy |
publishDate |
2021 |
url |
https://hdl.handle.net/10356/146533 |
_version_ |
1695706214446399488 |